Overview

Modafinil in Treating Fatigue in Patients Receiving Chemotherapy for Cancer

Status:
Completed
Trial end date:
2007-10-01
Target enrollment:
Participant gender:
Summary
RATIONALE: Modafinil may be effective in relieving fatigue in patients with cancer who are undergoing chemotherapy. The effectiveness of modafinil in relieving chemotherapy-related fatigue is not yet known. PURPOSE: This randomized phase III trial is studying the effectiveness of modafinil in treating fatigue in patients who are receiving chemotherapy for cancer.
Phase:
Phase 3
Details
Lead Sponsor:
Gary Morrow
Collaborator:
National Cancer Institute (NCI)
Treatments:
Armodafinil
Modafinil